A detailed history of Macquarie Group LTD transactions in Pfizer Inc stock. As of the latest transaction made, Macquarie Group LTD holds 5,958,769 shares of PFE stock, worth $164 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
5,958,769
Previous 5,710,297 4.35%
Holding current value
$164 Million
Previous $158 Million 5.22%
% of portfolio
0.2%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $6.28 Million - $7.35 Million
248,472 Added 4.35%
5,958,769 $167 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $12.7 Million - $14.6 Million
491,830 Added 9.42%
5,710,297 $158 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $686,722 - $891,977
-26,281 Reduced 0.5%
5,218,467 $150 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $18.5 Million - $21.6 Million
-576,756 Reduced 9.91%
5,244,748 $174 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $43 Million - $49.8 Million
1,191,243 Added 25.73%
5,821,504 $214 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $18.5 Million - $24.1 Million
469,856 Added 11.29%
4,630,261 $189 Million
Q4 2022

Feb 21, 2023

SELL
$41.75 - $54.5 $30.9 Million - $40.3 Million
-739,709 Reduced 15.1%
4,160,405 $213 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $19.8 Million - $24.2 Million
-453,528 Reduced 8.47%
4,900,114 $214 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $3.77 Million - $4.47 Million
-81,012 Reduced 1.49%
5,353,642 $281 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $45 Million - $55.8 Million
-983,867 Reduced 15.33%
5,434,654 $281 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $82.9 Million - $123 Million
2,006,883 Added 45.49%
6,418,521 $379 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $13.4 Million - $17.3 Million
-342,616 Reduced 7.21%
4,411,638 $190 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $4.48 Million - $5.08 Million
-124,850 Reduced 2.56%
4,754,254 $186 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $27.9 Million - $31.4 Million
831,643 Added 20.55%
4,879,104 $177 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $594 Million - $755 Million
-17,746,368 Reduced 81.43%
4,047,461 $149 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $36.2 Million - $42.5 Million
-1,140,819 Reduced 4.97%
21,793,829 $800 Million
Q2 2020

Aug 11, 2020

SELL
$30.12 - $36.54 $60.6 Million - $73.6 Million
-2,013,149 Reduced 8.07%
22,934,648 $750 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $40.1 Million - $57.4 Million
-1,484,982 Reduced 5.62%
24,947,797 $814 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $98.9 Million - $112 Million
3,005,472 Added 12.83%
26,432,779 $1.04 Billion
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $64.7 Million - $84 Million
1,992,715 Added 9.3%
23,427,307 $842 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $21.2 Million - $23.9 Million
-574,440 Reduced 2.61%
21,434,592 $929 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $4.82 Million - $5.3 Million
-128,535 Reduced 0.58%
22,009,032 $935 Million
Q4 2018

Feb 15, 2019

SELL
$38.47 - $43.86 $79.5 Million - $90.6 Million
-2,065,515 Reduced 8.53%
22,137,567 $966 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $39.2 Million - $47.5 Million
-1,137,080 Reduced 4.49%
24,203,082 $1.07 Billion
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $143 Million - $153 Million
4,344,595 Added 20.69%
25,340,162 $919 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $14.3 Million - $16.6 Million
449,273 Added 2.19%
20,995,567 $745 Million
Q4 2017

Feb 15, 2018

SELL
$33.26 - $35.29 $23 Million - $24.4 Million
-692,799 Reduced 3.26%
20,546,294 $743 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $658 Million - $725 Million
21,239,093
21,239,093 $758 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.